Company 3D Global Biotech Inc.

Equities

6808

TW0006808009

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sector Other Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
32.4 ^TWD	+0.15%		-0.15%	+66.58%

Apr. 19	3D Global Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	3D Global Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

3D Global Biotech Inc a biotechnology company mainly engaged in the development of medical materials for human reconstruction, focusing on the development of high-end medical equipment and biological printing technology. The Company mainly provides hard tissue reconstruction medical materials and soft tissue reconstruction medical materials. The hard tissue reconstruction medical materials mainly provide customized services for dental medical materials, original equipment manufacturer services for customized products of cranial implants, and orthopedics and dental reconstruction medical materials DGRA01: Î±-Former bone filling materials and the second-level medical equipment product of craniofacial jaw reconstruction medical materials DGRA03: SmileAlign transparent correction system. The soft tissue reconstruction medical materials mainly include bio-ink product DGRC02: 3D Bioture EX water gel stent.

Number of employees: 34

TWD in Million	2022	Weight	2023	Weight	Delta
Entrusted Technical Services 35.2 %	6	43.2 %	7	35.2 %	+23.20%
Others 23.4 %	2	11.9 %	5	23.4 %	+198.02%
Cranial Implant Customization Service 18.3 %	4	29.6 %	4	18.3 %	-6.41%
Technology License 13.8 %	-	-	3	13.8 %	-
Customized Dental Equipment Services 9.3 %	2	15.4 %	2	9.3 %	-8.69%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 100.0 %	14	100.0 %	21	100.0 %	+51.24%

Managers	Title	Age	Since
Keng Liang Ou CEO	Chief Executive Officer	-	15-01-14
Jui Wen Huang DFI	Director of Finance/CFO	-	17-04-17
Hsu An Pan CTO	Chief Tech/Sci/R&D Officer	-	20-01-31
Shu Hua Lin IRO	Public Communications Contact	-	17-05-22

Members of the board	Title	Age	Since
Ming Hsien Chen BRD	Director/Board Member	-	20-11-18
Chi Ying Chiu BRD	Director/Board Member	-	20-11-18
Keng Liang Ou CEO	Chief Executive Officer	-	15-01-14
Hsuan Che Liu BRD	Director/Board Member	-	20-11-18
Hsu Tung Li BRD	Director/Board Member	-	20-11-18
Chin Tang Chiu BRD	Director/Board Member	-	20-11-18
Tsung Mao Chen BRD	Director/Board Member	-	20-11-18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	56,809,000	45,923,073 ( 80.84 %)	0	80.84 %

3D Global Biotech, Inc.

21/F-3 99, Section 1, Xintai 5th Road

221416, New Taipei

http://www.3dglobalbiotech.com.tw

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
3D GLOBAL BIOTECH INC.	+66.58%	66.68M
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	68.11B
DEXCOM, INC.	+2.39%	50.53B
CENCORA, INC.	+9.36%	44.8B
HOYA CORPORATION	+2.70%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.51%	32.3B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.53B
ZIMMER BIOMET HOLDINGS, INC.	-0.32%	24.96B

Other Medical Equipment, Supplies & Distribution